[Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of the drug riamilovir for the prevention of COVID-19].
A U SabitovDmitriy A LioznovK V ZhdanovE P TihonovaE V EsaulenkoP V SorokinPublished in: Terapevticheskii arkhiv (2024)
).